May 14, 2026 04:10PM
May 13, 2026 04:01PM
Apr 21, 2026 08:30AM
Apr 21, 2026 08:30AM
Mar 31, 2026 04:05PM
Mar 30, 2026 04:05PM
Mar 30, 2026 04:05PM Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
Mar 25, 2026 04:01PM
Feb 23, 2026 09:24AM
Feb 23, 2026 09:24AM
Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM
Jan 13, 2026 07:45AM
Jan 13, 2026 07:45AM Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
Dec 15, 2025 08:03AM
Dec 15, 2025 08:00AM
Dec 10, 2025 08:30AM
Dec 10, 2025 08:30AM
Nov 14, 2025 08:30AM
Nov 12, 2025 04:01PM
Nov 6, 2025 07:01AM Axsome acquires Avenue's subsidiary for epilepsy drug development
Nov 6, 2025 07:00AM
Oct 24, 2025 08:30AM
Oct 24, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 21, 2025 08:30AM
Oct 1, 2025 08:05AM
Oct 1, 2025 08:00AM Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
Aug 14, 2025 04:05PM
Aug 12, 2025 04:01PM
Aug 7, 2025 08:30AM
Aug 7, 2025 08:30AM
Jul 14, 2025 08:31AM
Jul 14, 2025 08:30AM
Jul 7, 2025 08:32AM FDA grants orphan drug status to Mustang Bio's brain cancer treatment
Jul 7, 2025 08:30AM
Jun 24, 2025 08:31AM
Jun 24, 2025 08:30AM
Jun 20, 2025 08:32AM
Jun 20, 2025 08:30AM
Jun 9, 2025 08:30AM
May 30, 2025 10:48AM Fortress Biotech (FBIO) Closes Sale of Checkpoint Therapeutics
May 30, 2025 10:47AM
May 15, 2025 04:05PM
May 14, 2025 04:01PM
May 13, 2025 04:15PM
Apr 1, 2025 04:01PM
Mar 31, 2025 04:05PM
Mar 28, 2025 08:30AM Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
Mar 26, 2025 04:01PM

1,154,889 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All